Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 207

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 207
---
 — 53 53 Balances at June 30, 202437,596,927$376 5,309,529$53 $548,470 $(454,285)$(25)$94,589 

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

RAPID MICRO BIOSYSTEMS, INC.

Condensed consolidated statements of cash flows

(Unaudited)

(In thousands)

Six Months Ended June 30,20252024Cash flows from operating activities:Net loss$(23,121)$(25,900)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization expense1,658 1,634 Loss on fixed asset impairment19 — Stock-based compensation expense2,260 2,256 Provision for excess and obsolete inventory441 95 Noncash lease expense609 609 Accretion on investments149 (890)Other17 18 Changes in operating assets and liabilities:Accounts receivable1,471 521 Inventory(1,119)(1,564)Prepaid expenses and other current assets182 502 Other long-term assets— 1 Accounts payable800 207 Accrued expenses and other current liabilities(1,668)(2,586)Deferred revenue(463)(547)Net cash used in operating activities(18,765)(25,644)Cash flows from investing activities:Purchases of property and equipment(685)(1,044)Purchases of investments(2,290)(4,368)Maturity of investments23,000 43,744 Net cash provided by investing activities20,025 38,332 Cash flows from financing activities:Proceeds from issuance of Class A common stock - stock option exercise423 — Proceeds from issuance of Class A common stock - employee stock purchase plan90 168 Tax withholding on settlement of restricted stock units(418)— Payments on finance lease obligations(14)(20)Net cash provided by financing activities81 148 Net decrease in cash, cash equivalents and restricted cash1,341 12,836 Cash, cash equivalents and restricted cash at beginning of period17,276 24,569 Cash, cash equivalents and restricted cash at end of period$18,617 $37,405 

Six Months Ended June 30,20252024Supplemental disclosure of cash flow informationCash paid for interest$24 $17 Supplemental